Here we tested a DDX3X (DEAD box helicase) inhibitor (RK-33) [33–35] and three clinically established breast cancer chemotherapeutics: gemcitabine (GEM) [37], paclitaxel (PAC) [38], and doxorubicin (DOX) [36]. Here, DDX3X is linked to breast cancer.